The role of rituximab in a case of EBV-related lymphoproliferative disease presenting with haemophagocytosis.

Fulltext present in this item

Fulltext: 81171.pdf

Format: PDF

Description: publisher's version

Embargo: until further notice

Title:	The role of rituximab in a case of EBV-related lymphoproliferative disease presenting with haemophagocytosis.
Author(s):	Bosman, G.J.C.G.M. ; Langemeijer, S.M.C. ; Hebeda, K.M. ; Raemaekers, J.M.M. ; Pickkers, P. ; Velden, W.J.F.M. van der
Publication year:	2009
Source:	Netherlands Journal of Medicine, vol. 67, iss. 8, (2009), pp. 364-365
ISSN:	0300-2977
Publication type:	Article / Letter to editor
Please use this identifier to cite or link to this item : https://hdl.handle.net/2066/81171
Display more details
Subject:	N4i 1: Pathogenesis and modulation of inflammation NCMLS 2: Immune Regulation ONCOL 3: Translational research N4i 1: Pathogenesis and modulation of inflammation
Organization:	Biochemistry (UMC) CHL Haematology Laboratory of Hematology Pathology Intensive Care
Journal title:	Netherlands Journal of Medicine
Volume:	vol. 67
Issue:	iss. 8
Page start:	p. 364
Page end:	p. 365

Faculty of Medical Sciences [69652]
Electronic publications [82635]
Freely accessible full text publications plus those not yet available due to embargo
Academic publications [178812]
Academic output Radboud University